Press Releases Surmodics, Inc.

Equities

SRDX

US8688731004

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
25.85 ^USD	-1.22%		+1.81%	-28.89%

Feb. 06	Barrington Trims Price Target on SurModics to $70 From $71, Keeps Outperform Rating	MT
Feb. 01	Needham Adjusts SurModics' Price Target to $47 From $44, Maintains Buy Rating	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Surmodics to Report Second Quarter of Fiscal 2024 Financial Results on May 1	Apr. 22	AQ
Surmodics to Report Second Quarter of Fiscal 2024 Financial Results on May 1	Apr. 19	BU
Surmodics to Participate in Upcoming Investor Conferences in March and April	Feb. 27	BU
Surmodics Reports First Quarter of Fiscal Year 2024 Financial Results, Updates Fiscal Year 2024 Financial Guidance	Feb. 02	AQ
SurModics: Fiscal Q1 Earnings Snapshot	Feb. 01	AQ
Surmodics Reports First Quarter of Fiscal Year 2024 Financial Results; Updates Fiscal Year 2024 Financial Guidance	Feb. 01	BU
Surmodics Announces Successful Early Clinical Use of Pounce LP Thrombectomy System, Designed to Address a Critical, Unmet Need by Facilitating Removal of Thrombi and Emboli below the Knee	Jan. 23	AQ
Surmodics Announces Successful Early Clinical Use of Pounce™ LP (Low Profile) Thrombectomy System, Designed to Address a Critical, Unmet Need by Facilitating Removal of Thrombi and Emboli Below the Knee	Jan. 22	BU
Surmodics to Report First Quarter of Fiscal 2024 Financial Results on February 1	Jan. 16	BU
Surmodics to Host Virtual Annual Meeting of Shareholders	Jan. 16	BU
Surmodics Announces TRANSCEND Trial 36-Month Data Presented at 50th Annual VEITH Symposium	Nov. 16	BU
Surmodics Announces 24-Month Data from the SWING Trial Presented at VEITHsymposium	Nov. 16	BU
Surmodics to Participate in the Piper Sandler Healthcare Conference on November 28	Nov. 14	BU
SurModics: Fiscal Q4 Earnings Snapshot	Nov. 08	AQ
Surmodics Reports Fourth Quarter and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Financial Guidance	Nov. 08	BU
Surmodics : Reports Fourth Quarter and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Financial Guidance - Form 8-K	Nov. 08	PU
Surmodics Announces TRANSCEND Trial 36-Month Data to be Presented at 50th Annual VEITH Symposium	Nov. 07	BU
Surmodics Announces SWING Trial 24-Month Data to be Presented at VEITH Symposium on November 15	Nov. 07	BU
Surmodics Announces Launch of Preside Medical Device Coating Technology, Providing Industry-Leading Lubricity and Durability to a Broader Range of Complex Device Applications	Nov. 01	AQ
Surmodics Announces Launch of Preside™ Medical Device Coating Technology, Providing Industry-Leading Lubricity and Durability to a Broader Range of Complex Device Applications	23-10-31	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Surmodics, Inc.

Equities

SRDX

US8688731004

Press Releases

Filters